Investors

Press releases

November 2nd 2021 - Regulatory press releases
The long-term plan remains in challenging times
November 2nd 2021 - Regulatory press releases
Enzymatica Board decides on financial targets
October 18th 2021 - Regulatory press releases
Bulletin from the extraordinary general meeting in Enzymatica AB (publ)
September 29th 2021 - Regulatory press releases
Notice of extraordinary general meeting in Enzymatica AB (publ)
September 8th 2021 - Non-regulatory press releases
Claus Egstrand takes office as CEO ahead of schedule
August 11th 2021 - Non-regulatory press releases
Chinese and US patent authorities issue notices of allowance for patent for key component in cold spray ColdZyme
July 16th 2021 - Regulatory press releases
Continued lower sales due to pandemic but some stabilization
July 13th 2021 - Regulatory press releases
Claus Egstrand appointed new CEO of Enzymatica
July 12th 2021 - Regulatory press releases
Enzymatica and STADA extend agreement on ViruProtect to Vietnam
June 22nd 2021 - Non-regulatory press releases
Enzymatica appoints new Director of Quality Assurance and Communication Manager
June 7th 2021 - Regulatory press releases
Enzymatica announces outcome of new rights issue
June 3rd 2021 - Non-regulatory press releases
Enzymatica launches ColdZyme on Amazon
May 21st 2021 - Non-regulatory press releases
Patent for ColdZyme approved in Japan
May 12th 2021 - Regulatory press releases
Prospectus for Enzymatica’s rights issue is published
May 5th 2021 - Regulatory press releases
Bulletin from Annual General Meeting of Enzymatica AB (publ) on 5 May 2021
April 29th 2021 - Regulatory press releases
Lower sales due to the pandemic but new rights issue secures continued international expansion
March 31st 2021 - Regulatory press releases
Enzymatica Publication of the Annual Report 2020
March 31st 2021 - Regulatory press releases
Notice of Annual General Meeting 2021 in Enzymatica AB (publ)
March 29th 2021 - Regulatory press releases
Enzymatica’s Board of Directors decides on a new rights issue of SEK 59.1 million
March 22nd 2021 - Regulatory press releases
Enzymatica’s sales and result affected by the pandemic
February 18th 2021 - Regulatory press releases
Positive operating result and almost doubled sales for the fourth quarter
February 11th 2021 - Regulatory press releases
Enzymatica comments on article in Dagens Medicin
January 15th 2021 - Non-regulatory press releases
New strategic recruitments and organizational changes at Enzymatica